编号：2025-011 | | 特定对象调研 □分析师会议 | | --- | --- | | | 媒体采访 □业绩说明会 | | 调研活动类别 | □新闻发布会 □路演活动 | | | 现场参观 其他 | | 参与单位名称 | 康曼德资本、中泰证券、人保资产、国信证券 | | 时 间 | 2025 年 11 月 20 日下午 14:00-16:00 | | 地 点 | 公司会议室 | | 上市公司接待 | 董事会秘书：黄玉婷 | | 人员姓名 | 证券事务代表：周德伟 | | | 一、内容提要： | | | 1、厂区参观 | | | 2、会议室座谈 | | | 二、主要关注的问题与回复如下： | | | 1、公司的海外市场拓展方向和策略介绍。 | | | 国际市场拓展，公司目前主要聚焦东南亚、中东非、欧洲、 | | | 美洲、印度新澳五大区域，推动高质量销售与服务落地，依托行 | | | 业稀缺的整体解决方案能力、高性价比服务及渠道优势拓展客户。 | | 交流内容 | 后续欧洲、美洲区域订单与业绩有望实现逐步突破，中东非、 | | | 东南亚区域已取得阶段性突破性成果，整体海外业务已进入快速 | | ...

Group 1: Financial Performance - In the first half of 2025, the company achieved revenue of 2.417 billion yuan, a decrease of 14.55% compared to the same period last year [2] - The non-recurring net profit loss was 49 million yuan, significantly narrowing compared to the previous year [2] - The overall gross margin improved from approximately 26% in 2024 to nearly 30% in the first half of 2025, indicating enhanced operational and contract quality [4] Group 2: Business Strategy and Operations - The company is focusing on improving operational quality, with efforts including increased international business expansion, which saw nearly 40% growth in overseas revenue in the first half of 2025 [2] - Domestic order quality is improving, with new order gross margins gradually returning to normal levels despite intense competition in the domestic market [2] - The company is actively pursuing cost reduction and efficiency improvements across management, R&D, procurement, and manufacturing [2] Group 3: International Business Development - The company’s international business has seen significant changes, with major pharmaceutical companies beginning supplier audits, leading to breakthroughs in cooperation [3] - In the first half of 2025, the company experienced strong growth in the Middle East and Southeast Asia, with hopes of increasing the proportion of international business in the coming years [2][3] - Romaco Group, a subsidiary, is performing well with steady improvements, and currently has no plans for further overseas capacity expansion [3] Group 4: Market Conditions and Competition - The domestic market remains competitive, with price sensitivity; however, the price competition has improved compared to last year, suggesting a bottoming out of pricing pressures [3] - The company plans to selectively abandon low-margin orders to enhance operational quality while maintaining scale [3]